Employees: 11-50
Total raised: $43M
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | Blumberg C... | blumbergca... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 27.05.2022 | Seed | $21.5M | Blumberg C... |
| 03.05.2022 | Series A | $21.5M | - |
Mentions in press and media 7
| Date | Title | Description |
| 23.09.2024 | Стартап в области медицинских технологий использует искусственный интеллект Oracle для исследования лекарств от рака... | В последние годы, благодаря человеческой изобретательности и научным достижениям, были разработаны новые препараты, которые обещают облегчение и даже выздоровление миллионам людей по всему миру, живущих с ранее неизлечимыми формами рака. Чт... |
| 27.05.2022 | Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer | Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, announced it raised $21.5 million, comprising $3 million in seed funding led by Blumberg Capital and an $18.5 million Series A round led by renowned tech... |
| 03.05.2022 | Imagene AI Raises $21.5M in Seed and Series A | Imagene AI, a Tel Aviv, Israel-based precision oncology diagnosis company, raised $21.5m in funding. The funding included: $3m in seed funding led by Blumberg Capital, and $18.5m in Series A round led by Larry Ellison, Dr. David Agus, and E... |
| 02.05.2022 | Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer | Imagene's proprietary deep learning algorithms reduce the time required for biomarkers detection from several weeks to two minutes – allowing more cancer patients to receive the most effective treatment possible Larry Ellison and Dr. David ... |
| 02.05.2022 | Imagene Raises $21.5M to Expand Image-Based Biomarker Detection for Precision Medicine | What You Should Know: – Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced it raised $21.5 million, comprising $3M in seed funding led by Blumberg Capital and an $18.5M Series A round led ... |
| - | At Biomed Israel conference, medical start-ups discuss challenges in reaching success Into the Land: The Forgery Scandal | The worldwide economic downturn and Israel’s internal political turmoil have investors sitting on the fence about funding local tech companies. However, that did not prevent thousands of industry leaders from 45 countries from attending the... |
| - | StartUPDATES: New developments for healthcare startups | Healthmine‘s Executive Vice President of Consulting & Professional Services Melissa Smith shared six takeaways from the 2023 Medicare Advantage and Part D Final Rule. Learn how to successfully navigate the regulatory updates by clicking... |